Received Mar 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | PO / MO |
The patient accidentally took doses of Vivotif with food; Case reference number US-BN-2024-002763 is a spontaneous case initially received from a consumer via Med Communications (reference number: USBAV24-2967) on 08-Nov-2024 and concerns a female patient of unknown age. The patient's medical history and concomitant medications were not provided. On an unspecified date, the patient accidently took with food the doses of Vivotif (batch number: unknown and expiration date: unknown) at unknown dose, orally for protection against typhoid fever (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20241108-ba13d6 to US-BAVARIAN NORDIC A/S-US-BN-2024-002763, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A female patient of unknown age accidently took the doses of Vivotif for protection against typhoid fever with food, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unknown age accidently took the doses of Vivotif for protection against typhoid fever with food, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.